- Brooke Shields convenes other
celebrities, influencers and patient advocates over 50 to discuss
the power of aging and how to protect their health
- Shields directs a short film, encouraging adults 50 years of
age and older to talk to their doctor or pharmacist about their
risk for shingles — a disease that affects about 1 million people
annually in the US — and about vaccination
- The partnership is part of GSK's national THRIVE@50+
campaign
PHILADELPHIA, Sept. 16,
2024 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) is
partnering with Brooke Shields, as
part of its THRIVE@50+ campaign, to encourage people 50 and older
to embrace and protect the power they've found in aging by asking
their doctor or pharmacist about their risk for shingles and about
vaccination.
Experience the full interactive Multichannel News Release here:
https://www2.multivu.com/gsk/9290451-en-brooke-shields-gsk-shingles-risk-adults-50-and-older
Shields exemplifies what it means to thrive at any age,
including now, at her current age of 59. The actress, TV
personality, model and entrepreneur now adds fierce health advocate
to her resume. Like so many others her age, at a time when Shields
was stepping into a new, unapologetic power, she also learned that
with age comes the important lesson of protecting one's health from
vulnerabilities like shingles. In fact, 99% of people over the age
of 50 are at risk for developing shingles, although not everyone
will.1
Brooke Shields
said: "For so long, we've been conditioned to fear aging,
but the reality is that age is power. As I've gotten older, my life
experiences have really solidified who I am and what I stand for,
and when I talked to other women who were a part of this campaign,
it's clear that I'm not the only one who feels this way. The unfair
twist is that just as we've reached this time of our lives where we
feel like the best version of ourselves, we're also experiencing
new health risks. When I learned that people over 50 are at an
increased risk for shingles, I couldn't help myself from starting
the conversation. This matters because our power is worth
protecting."
Part of Shields' partnership with GSK's THRIVE@50+ campaign
involved her directing and producing videos with other influential
women who are thriving in their 50s and beyond, including football
mom Donna Kelce, actress
Gina Torres, reality TV star
Susan Noles and former shingles
patients, among others, each sharing their own unique stories and
radiating the power they've come into with age. World-renowned
fashion and lifestyle photographer Pamela
Hanson joined the group to capture that power in her iconic
portrait style.
Leah Smith, PharmD, GSK
medical educator, said: "Shingles can be an isolating
experience that can also really take a toll on one's quality of
life. And it's not as uncommon as you might think — every year,
there are about one million cases of shingles in the US alone. Age
is the most important risk factor for shingles, so anyone over 50
should consider asking their doctor or pharmacist about shingles
and about vaccination."
GSK's goal with their THRIVE@50+ campaign is to create a
cultural movement around healthy aging, grounded in the genuine and
authentic experiences that bring the community together.
About THRIVE@50+
THRIVE@50+ is a national public health initiative from GSK to
educate people 50 and older about their risk for shingles, due to
the natural aging of the immune system, and the impact the disease
can have on everyday life. We encourage people 50 and older to
understand how they can help prevent shingles, like asking their
doctor or pharmacist about their risk of shingles and about
vaccination, so they can stay ahead of this health challenge and
continue to thrive.
About shingles
Shingles is caused by the reactivation of the varicella-zoster
virus (VZV), the same virus that causes
chickenpox.1 By age 50, VZV is present in most
adults2 and may reactivate with advancing
age.3 As people age, the strength of the immune
system's response to infection wanes, increasing the risk of
developing shingles.1
Shingles typically presents as a rash, with painful blisters
across the chest, abdomen or face.3 The pain is
often described as aching, burning, stabbing or
shock-like.4
Following the rash, a person may experience post-herpetic
neuralgia (PHN), a long-lasting nerve pain that can last weeks or
months and occasionally persists for several
years.4 PHN is the most common complication of
shingles, occurring in 5–30% of all shingles cases, from findings
in various studies.5
About GSK
GSK is a global biopharma company with a purpose to unite science,
technology, and talent to get ahead of disease together. Find out
more at gsk.com.
Cautionary statement regarding forward-looking
statements
GSK cautions investors that any forward-looking statements or
projections made by GSK, including those made in this announcement,
are subject to risks and uncertainties that may cause actual
results to differ materially from those projected. Such factors
include, but are not limited to, those described under Item 3.D
"Risk factors" in GSK's Annual Report on Form 20-F for 2023, and
GSK's Q2 Results for 2024.
Registered in England &
Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG
References:
- CDC. Shingles (Herpes Zoster): Clinical Overview. Available
at: https://www.cdc.gov/shingles/hcp/clinical-overview/
- Johnson RW, et al. Herpes zoster epidemiology, management, and
disease and economic burden in Europe: a multidisciplinary perspective. Ther
Adv Vaccines. 2015;3(4):109-120.
- Mueller NH, et al. Varicella zoster virus infection: clinical
features, molecular pathogenesis of disease and latency. Neurologic
Clinics. 2008;26;675-697.
- Cheng J, Rosenquist RW. Herpes zoster and postherpetic
neuralgia. Fundamentals of Pain Medicine. 2018:221-5.
- Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of
incidence and complications of herpes zoster: towards a global
perspective. BMJ Open. 2014;4:e004833. doi:
10.1136/bmjopen-2014-0048
View original
content:https://www.prnewswire.com/news-releases/brooke-shields-partners-with-gsk-to-educate-adults-50-and-older-about-their-shingles-risk-302249282.html
SOURCE GSK